Matthias Hoffmann

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

Juliet N. Barker, Matthias Hoffmann, Gottfried Wozel et al. · British Journal of Dermatology · 2011 · 201 citations

Medicine, Pharmacology, Pharmacotherapy +12

The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial

Pietro Vernazza, Synøve Daneel, Véronique Schiffer et al. · AIDS · 2007 · 97 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Vitamin B<sub>12</sub> Cream Containing Avocado Oil in the Therapy of Plaque Psoriasis

Markus Stücker, U. Memmel, Matthias Hoffmann et al. · Dermatology · 2001 · 72 citations

Medicine, Dermatology, Pharmacotherapy +8

Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial

Sascha Gerdes, Beate Bräu, Matthias Hoffmann et al. · The Journal of Dermatology · 2021 · 47 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies

Sonja Fernbach, Nina K. Mair, Irène A. Abela et al. · The Journal of Experimental Medicine · 2024 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17